CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 35 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $115,000 | +33.7% | 20,000 | 0.0% | 0.02% | +11.1% |
| Q1 2017 | $86,000 | +145.7% | 20,000 | 0.0% | 0.02% | +125.0% |
| Q4 2016 | $35,000 | -10.3% | 20,000 | 0.0% | 0.01% | -20.0% |
| Q3 2016 | $39,000 | +11.4% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q2 2016 | $35,000 | +29.6% | 20,000 | 0.0% | 0.01% | +50.0% |
| Q1 2016 | $27,000 | -20.6% | 20,000 | 0.0% | 0.01% | -11.1% |
| Q4 2015 | $34,000 | +9.7% | 20,000 | 0.0% | 0.01% | +12.5% |
| Q3 2015 | $31,000 | -42.6% | 20,000 | 0.0% | 0.01% | -42.9% |
| Q2 2015 | $54,000 | -60.9% | 20,000 | 0.0% | 0.01% | -67.4% |
| Q1 2015 | $138,000 | -29.9% | 20,000 | 0.0% | 0.04% | -44.2% |
| Q4 2014 | $197,000 | +43.8% | 20,000 | 0.0% | 0.08% | +18.5% |
| Q3 2014 | $137,000 | – | 20,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |